Arcutis Biotherapeutics Inc (ARQT)
8.00
+0.01
(+0.13%)
USD |
NASDAQ |
May 09, 16:00
8.00
0.00 (0.00%)
After-Hours: 16:54
Arcutis Biotherapeutics Profit Margin (Quarterly): -490.0% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -490.0% |
September 30, 2023 | -117.5% |
June 30, 2023 | -1.37K% |
Date | Value |
---|---|
March 31, 2023 | -2.88K% |
December 31, 2022 | -2.43K% |
September 30, 2022 | -14.86K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.86K%
Minimum
Sep 2022
-117.5%
Maximum
Sep 2023
-3.69K%
Average
-1.90K%
Median
Profit Margin (Quarterly) Benchmarks
AdaptHealth Corp | -0.36% |
Puma Biotechnology Inc | -11.00% |
Adverum Biotechnologies Inc | -- |
Apellis Pharmaceuticals Inc | -38.55% |
Karuna Therapeutics Inc (DELISTED) | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -231.9% |
Return on Assets | -73.48% |
Return on Invested Capital | -83.80% |
Gross Profit Margin (Quarterly) | 83.39% |
Operating Margin (Quarterly) | -452.2% |
Return on Net Operating Assets | -575.9% |